The effects of physostigmine in phenothiazine resistant chronic schizophrenic patients: preliminary observations.
D000284:Administration, Oral; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D010640:Phenothiazines; D010830:Physostigmine / Q000008:administration & dosage / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D010640:Phenothiazines; D010830:Physostigmine